Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Emory University
Emory University
Stanford University
Jonsson Comprehensive Cancer Center
Northwestern University
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology